Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983733 · ClinicalTrials.gov registry record · NA
PREDICT 2: Personalized Responses to Dietary Composition Trial 2
A NA study, sponsored by Zoe Global Limited.
- Completed
- Registry status
- NA
- Development phase
- 1,139
- Enrollment target
NCT03983733 is a NA study that has completed, run by Zoe Global Limited. The registered enrollment target is 1,139 participants.
The verdict
NCT03983733, a NA study, has completed, sponsored by Zoe Global Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,139 participants
- Enrollment target
Study Summary
Foods in the human diet can affect the development of diseases over time, such as diabetes or heart disease. This is because the amount and types of foods in the diet eat can affect a person's weight, and because different foods are metabolised (processed) by the body in different ways. Scientists have also found that the bacteria in the human gut (the gut microbiome) affect their metabolism, weight and health and that, together with a person's diet and metabolism, could be used to predict appetite and how meals affect the levels of sugar (glucose) and fats (lipids) found in blood after eating. If blood sugar and fat are too high too often for too long, there is a greater chance of developing diseases such as diabetes and cardiovascular disease. The gut microbiome is different in different people. Only 10-20% of the types of bacteria found in the human gut are found in everyone. This might mean that the best diet to prevent disease needs matching to a person's gut microbiome and it might be possible to find personalised foods or diets that will help reduce the chance of developing chronic disease as well as metabolic syndrome. The study investigators are recruiting volunteers aged 18-70 years to take part in a study that aims to answer the questions above. Participants will be asked to consume standardised meals on up to 8 days while wearing glucose monitors (Abbott Freestyle Libre) to measure their blood sugar levels. Participants will also be required to prick their fingers at regular intervals to collect small amounts of blood, and to record their appetite, food, physical activity and sleep using apps and wearable devices. They will be asked to collect a fecal and saliva sample before consuming the standardised meals, and to provide a fasted blood sample at the end of the study period.
Interventions
- OTHER Dietary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,139 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983733
The ClinicalTrials.gov registry entry for NCT03983733 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoe Global Limited, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary Intervention is the first listed.
NCT03983733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983733 about?
NCT03983733 is a clinical study titled "PREDICT 2: Personalized Responses to Dietary Composition Trial 2". Foods in the human diet can affect the development of diseases over time, such as diabetes or heart disease. This is because the amount and types of foods in the diet eat can affect a person's weight, and because different foods are metabolised (processed) by the body in different ways. Scientists ...
What is the current status of trial NCT03983733?
This trial is currently completed. It is a NA study. The enrollment target is 1,139 participants. The study started on 2019-06-10. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03983733?
The interventions under investigation include: Dietary Intervention (OTHER).
Who is sponsoring clinical trial NCT03983733?
This trial is sponsored by Zoe Global Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.